Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
M Mansilla-Polo, D Morgado-Carrasco - Dermatology and Therapy, 2024 - Springer
Introduction The risk of infections associated with biological drugs (BD) and Janus kinase
inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth …
inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth …